391817003: Bendrofluazide - chemical (substance)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2007. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1465997013 Bendrofluazide - chemical (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

1485811019 Bendrofluazide - chemical en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

2536615011 Bendroflumethiazide - chemical en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Bendrofluazide - chemical	Is a	Diuretic (substance)	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Bendroflumethiazide 2.5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendrofluazide - chemical	Inferred relationship	Some
bendrofluazid 2,5 mg + kalium 7,7 mmol tablet med modificeret udløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendrofluazide - chemical	Inferred relationship	Some
bendrofluazid 2,5 mg + kalium 8,4 mmol tablet med modificeret udløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendrofluazide - chemical	Inferred relationship	Some
Bendroflumethiazide 5 mg and nadolol 40 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendrofluazide - chemical	Inferred relationship	Some
Product containing precisely bendroflumethiazide 5 milligram and nadolol 80 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendrofluazide - chemical	Inferred relationship	Some
Bendroflumethiazide 2.5 mg and timolol maleate 10 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendrofluazide - chemical	Inferred relationship	Some
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendrofluazide - chemical	Inferred relationship	Some
propranololhydrochlorid 160 mg + bendrofluazid 5 mg kapsel med modificeret udløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendrofluazide - chemical	Inferred relationship	Some
Bendroflumethiazide + nadolol 5mg/40mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendrofluazide - chemical	Inferred relationship	Some
Bendroflumethiazide + nadolol 5mg/80mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendrofluazide - chemical	Inferred relationship	Some
Propranolol hydrochloride + bendrofluazide	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendrofluazide - chemical	Inferred relationship	Some

Reference Sets

Concept inactivation indicator reference set

SAME AS association reference set (foundation metadata concept)